WallStreetZenWallStreetZen

NYSE: MPT
Medical Properties Trust Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MPT

Based on 2 analysts offering 12 month price targets for Medical Properties Trust Inc

Min Forecast
$5.00+6.16%
Avg Forecast
$5.00+6.16%
Max Forecast
$5.00+6.16%

Should I buy or sell MPT stock?

Based on 2 analysts offering ratings for Medical Properties Trust Inc.

Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
1 analysts 50%
Although MPT's forecast from analysts indicates a "Sell", our proven Zen Rating quant model rates MPT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their MPT stock forecasts and price targets.

MPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-02
lockedlocked$00.00+00.00%2025-11-25

1 of 1

Forecast return on equity

Is MPT forecast to generate an efficient return?

Company
N/A
Industry
5.89%
Market
179.62%

Forecast return on assets

Is MPT forecast to generate an efficient return on assets?

Company
N/A
Industry
3.44%

MPT earnings per share forecast

What is MPT's earnings per share in the next 2 years based on estimates from 6 analysts?

Avg 1 year Forecast
$0.09
Avg 2 year Forecast
$0.16

MPT revenue forecast

What is MPT's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$1.0B+3.91%
Avg 2 year Forecast
$1.1B+8.85%
Avg 3 year Forecast
$1.1B+8.54%
MPT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MPT revenue growth forecast

How is MPT forecast to perform vs REIT - Healthcare Facilities companies and vs the US market?

Company
3.46%
Industry
11.38%
Market
13.42%
MPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MPT vs Healthcare Facility REIT Stocks

TickerPricePrice TargetUp/downsideConsensus
MPT$4.71$5.00+6.16%Sell
LTC$38.38$39.00+1.62%Hold
DHC$7.15$7.25+1.40%Buy
NHI$84.81$88.75+4.65%Strong Buy
SILA$24.22$26.00+7.35%Buy
View Top Healthcare Facility REIT Stocks

Medical Properties Trust Stock Forecast FAQ

Is Medical Properties Trust Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: MPT) stock is to Sell MPT stock.

Out of 2 analysts, 0 (0%) are recommending MPT as a Strong Buy, 0 (0%) are recommending MPT as a Buy, 1 (50%) are recommending MPT as a Hold, 0 (0%) are recommending MPT as a Sell, and 1 (50%) are recommending MPT as a Strong Sell.

If you're new to stock investing, here's how to buy Medical Properties Trust stock.

What is MPT's earnings growth forecast for 2026-2027?

(NYSE: MPT) Medical Properties Trust's forecast annual earnings growth rate of N/A is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast earnings growth rate of 30.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.93%.

Medical Properties Trust's earnings in 2026 is -$277,049,000.On average, 6 Wall Street analysts forecast MPT's earnings for 2026 to be $55,526,330, with the lowest MPT earnings forecast at $29,287,300, and the highest MPT earnings forecast at $87,861,900.

In 2027, MPT is forecast to generate $95,094,070 in earnings, with the lowest earnings forecast at $70,289,520 and the highest earnings forecast at $138,068,700.

What is MPT's revenue growth forecast for 2026-2028?

(NYSE: MPT) Medical Properties Trust's forecast annual revenue growth rate of 3.46% is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast revenue growth rate of 11.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.42%.

Medical Properties Trust's revenue in 2026 is $972,022,000.On average, 9 Wall Street analysts forecast MPT's revenue for 2026 to be $603,677,000,000, with the lowest MPT revenue forecast at $553,362,614,000, and the highest MPT revenue forecast at $653,883,800,000. On average, 7 Wall Street analysts forecast MPT's revenue for 2027 to be $632,366,600,000, with the lowest MPT revenue forecast at $548,389,750,000, and the highest MPT revenue forecast at $698,711,300,000.

In 2028, MPT is forecast to generate $630,573,500,000 in revenue, with the lowest revenue forecast at $612,044,800,000 and the highest revenue forecast at $655,676,900,000.

What is MPT's forecast return on assets (ROA) for 2026-2029?

(NYSE: MPT) forecast ROA is N/A, which is lower than the forecast US REIT - Healthcare Facilities industry average of 3.44%.

What is MPT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year MPT price target, the average MPT price target is $5.00, with the highest MPT stock price forecast at $5.00 and the lowest MPT stock price forecast at $5.00.

On average, Wall Street analysts predict that Medical Properties Trust's share price could reach $5.00 by Mar 2, 2027. The average Medical Properties Trust stock price prediction forecasts a potential upside of 6.16% from the current MPT share price of $4.71.

What is MPT's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: MPT) Medical Properties Trust's current Earnings Per Share (EPS) is -$0.46. On average, analysts forecast that MPT's EPS will be $0.09 for 2026, with the lowest EPS forecast at $0.05, and the highest EPS forecast at $0.15. In 2027, MPT's EPS is forecast to hit $0.16 (min: $0.12, max: $0.23).

What is MPT's forecast return on equity (ROE) for 2026-2029?

(NYSE: MPT) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.